Skip to main content
. 2011 Jul 14;17(19-20):2497–2509. doi: 10.1089/ten.tea.2010.0705

Table 1.

Treatment Groups

Treatment Scaffold rhNell-1 Pericytes n (implants)
Carrier Alone hCBC (100 μL) 50 mg TCP alone None 8
Nell-1 Alone hCBC (100 μL) 15 μg Nell-1 in 50 mg TCP None 8
Pericyte Alone hCBC (100 μL) 50 mg TCP alone 2.5×105 in 20 μL 8
Pericyte+Nell-1 hCBC (100 μL) 15 μg Nell-1 in 50 mg TCP 2.5×105 in 20 μL 8
Pericyte+Nell-1 hCBC (100 μL) 100 μg Nell-1 in 50 mg TCP 2.5×105 in 20 μL 8
Pericyte+Nell-1 hCBC (100 μL) 300 μg Nell-1 in 50 mg TCP 2.5×105 in 20 μL 8

hCBC, human cortical/cancellous bone chip; TCP, tricalcium phosphate.